BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

657 related articles for article (PubMed ID: 15302795)

  • 1. Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes.
    Lee KW; Lip GY; Blann AD
    Circulation; 2004 Oct; 110(16):2355-60. PubMed ID: 15302795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
    Nadar SK; Blann A; Beevers DG; Lip GY
    J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure.
    Chong AY; Caine GJ; Freestone B; Blann AD; Lip GY
    J Am Coll Cardiol; 2004 Feb; 43(3):423-8. PubMed ID: 15013125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.
    Lip PL; Chatterjee S; Caine GJ; Hope-Ross M; Gibson J; Blann AD; Lip GY
    Br J Ophthalmol; 2004 Dec; 88(12):1543-6. PubMed ID: 15548809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma markers of angiogenesis in pregnancy induced hypertension.
    Nadar SK; Karalis I; Al Yemeni E; Blann AD; Lip GY
    Thromb Haemost; 2005 Nov; 94(5):1071-6. PubMed ID: 16363251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiopoietin 1 (Ang-1), angiopoietin 2 (Ang-2) and Tie-2 (a receptor tyrosine kinase) concentrations in peripheral blood of patients with thyroid cancers.
    Niedźwiecki S; Stepień T; Kopeć K; Kuzdak K; Komorowski J; Krupiński R; Stepień H
    Cytokine; 2006 Dec; 36(5-6):291-5. PubMed ID: 17374490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in vascular endothelial growth factor, angiopoietins, and Tie-2 levels with G-CSF stimulation in healthy donors.
    Serefhanoglu S; Goker H; Buyukasik Y; Turgut M; Sayinalp N; Haznedaroglu IC; Aksu S; Akman U; Ozcebe OI
    Ann Hematol; 2009 Jul; 88(7):667-71. PubMed ID: 19082594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment.
    Mohan JS; Lip PL; Blann AD; Bareford D; Lip GY
    Br J Ophthalmol; 2005 Jul; 89(7):815-9. PubMed ID: 15965157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia.
    Lee CY; Tien HF; Hu CY; Chou WC; Lin LI
    Br J Cancer; 2007 Oct; 97(7):877-82. PubMed ID: 17848952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal regulation of angiopoietin-1 and angiopoietin-2 following myocardial infarction in the rat.
    Sandhu R; Teichert-Kuliszewska K; Nag S; Proteau G; Robb MJ; Campbell AI; Kuliszewski MA; Kutryk MJ; Stewart DJ
    Cardiovasc Res; 2004 Oct; 64(1):115-24. PubMed ID: 15364619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in plasma vascular endothelial growth factor, angiopoietins, and their receptors following surgery for breast cancer.
    Caine GJ; Stonelake PS; Lip GY; Blann AD
    Cancer Lett; 2007 Apr; 248(1):131-6. PubMed ID: 16891056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of soluble angiopoietin-2 and Tie-2 in patients with inflammatory bowel disease.
    Koutroubakis IE; Xidakis C; Karmiris K; Sfiridaki A; Kandidaki E; Kouroumalis EA
    Eur J Clin Invest; 2006 Feb; 36(2):127-32. PubMed ID: 16436095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients.
    Nadar S; Blann AD; Lip GY
    Am J Hypertens; 2006 Sep; 19(9):970-7; discussion 978. PubMed ID: 16942942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic and intracardiac vascular endothelial growth factor and angiopoietin-1 and -2 levels in coronary artery disease: effects of angioplasty.
    Jaumdally RJ; Varma C; Blann AD; MacFadyen RJ; Lip GY
    Ann Med; 2007; 39(4):298-305. PubMed ID: 17558601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant decrease in angiopoietin-1 and angiopoietin-2 after radical prostatectomy in prostate cancer patients.
    Caine GJ; Ryan P; Lip GY; Blann AD
    Cancer Lett; 2007 Jun; 251(2):296-301. PubMed ID: 17240049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiopoietin 2 and cardiovascular disease in dialysis and kidney transplantation.
    David S; Kümpers P; Hellpap J; Horn R; Leitolf H; Haller H; Kielstein JT
    Am J Kidney Dis; 2009 May; 53(5):770-8. PubMed ID: 19268412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal resection is associated with persistent proangiogenic plasma protein changes: postoperative plasma stimulates in vitro endothelial cell growth, migration, and invasion.
    Kumara HM; Feingold D; Kalady M; Dujovny N; Senagore A; Hyman N; Cekic V; Whelan RL
    Ann Surg; 2009 Jun; 249(6):973-7. PubMed ID: 19474682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiopoietin-2 levels as a biomarker of cardiovascular risk in patients with hypertension.
    Patel JV; Lim HS; Varughese GI; Hughes EA; Lip GY
    Ann Med; 2008; 40(3):215-22. PubMed ID: 18382887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma and platelet-derived vascular endothelial growth factor and angiopoietin-1 in hypertension: effects of antihypertensive therapy.
    Nadar SK; Blann AD; Lip GY
    J Intern Med; 2004 Oct; 256(4):331-7. PubMed ID: 15367176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the angopoietin-1, angopoietin-2, Tie2, and vascular endothelial growth factor gene in epithelial ovarian cancer.
    Hata K; Nakayama K; Fujiwaki R; Katabuchi H; Okamura H; Miyazaki K
    Gynecol Oncol; 2004 Apr; 93(1):215-22. PubMed ID: 15047239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.